Merlin_Asset (@Merlin_Asset) header
Merlin_Asset (@Merlin_Asset) profile picture

“Always Be Learning” - Tweets are not recommendation. Do your own due diligence. Sector and Market Cap Agnostic

Joined April 2015
Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)Photo by Merlin_Asset (@Merlin_Asset)
On the weekend the FDA rejected $SMMT drug. PFS win, but OS missed: HR 0.79, p=0.057. Not enough. 48 hours later Sellas $SLS hits OS outright in AML: 24.0 vs 14.7 months median survival HR 0.59, p=0.035 The catch: 126 patients, 80 deaths. A small trial, but on the right endpoint. The FDA just told everyone which endpoint it pays for. Sellas plans its BLA for 1H 2027
1
323
This must be the reason copper is rolling over. Clearly bringing on too much supply!
Britain's copper crime wave has become brazen and out of control, with thieves filming themselves slicing out cables all over the country to cash in on the precious metal inside. @TomSkyNews investigates. 📺 trib.al/hO3OZDT
1
1
314
Merlin_Asset retweeted
Confirmed: he blew up, loaded up on calls hoping to make it all back quick, then blew up again.
He's baaaaack: "Somebody" just spent $100MM premium on 2 week AI Stock Calls for the Oct2 expiration: INTC Oct2nd 115c bot up to 3.65 20k $7.3MM MRVL Oct2nd 250c bot 11.00 3500x $3.85MM SNDK Oct2nd 1600c bot up to 97.60 4200x $41MM MU oct 2nd 1000c bot up to 44.00 10k $44MM
522
845
278
11,979
1,345,230
The regulator reads the pre-specified analysis, not the follow-up you wish you'd planned. FDA just told $SMMT that PFS isn't enough. China approved the same drug in the same setting in May 2024. Same drug, different bar. $XBI
76
Canadian Natural Resources $CNQ.TO said it agreed to acquire Advantage Energy $AAV.TO for CA$13.55 ($9.49) per share in cash.
125
Quebecor’s $QBR.B.TO offer is worth about C$19.45 per share, valuing Telus $T.TO at around C$31 billion ($21.7 billion). That would be a 60% premium to Friday’s closing share price.
209
Summit $SMMT announced the FDA rejection today for ivonescimab plus chemo in EGFR-mutated lung cancer patients whose earlier targeted drugs stopped working. The FDA wanted a statistically significant survival benefit, and HARMONi didn't show one. $XBI
1
380
CANACCORD $CF.TO ENTERS INTO AGREEMENT TO BE TAKEN PRIVATE BY CHAIRMAN AND CEO DAN DAVIAU Shareholders to receive aggregate consideration of $15.27 per common share comprised of $7.45, plus proceeds of £4.15
3
4
19
4,887
This is the exact issue with AI Drug Discovery. They still have to “operate at the speed of life”. It still takes years to run a clinical trial. $XBI $LLY
Will AI cure all diseases over the next decade? We asked @BenjamineYLiu.
1
103
Merlin_Asset retweeted
Ok let me get this straight: - The most charismatic CEO in AI, who happens to be an open source proponent (which is obviously bad for Frontier models), gets ousted because of “surprise” leaks about his affair(s) - Microsoft suffers a global outage, just a few days after Anthropic unveils an Office competitor - just as Anthropic is about to IPO … and none of you think this is weird at all?!! The Golden Age of Rift ™️ is upon us
73
138
20
1,422
87,084
Altius Minerals to Acquire TNR Gold in C$122 Million Cash The deal represents an implied consideration of about C$0.48 per TNR share, a 60% premium to the stock's closing price on Tuesday, which is listed on the TSX Venture Exchange Congrats @YellowLabLife on surfacing the value.
2
1
6
632
Mirum $MIRM brelovitug in hepatitis delta. Second Phase 3 win in two months. AZURE-4 at week 24: 300 mg weekly: 59% hit the combined endpoint 900 mg monthly: 44% Delayed-treatment arm: 0% The real story is the 108-week data in cirrhosis patients, with 100% virologic response and 100% ALT normalization (only 15 patients). Half of these patients are cirrhotic and there's no approved HDV drug in the US. BLA is planned for H1 2027, and Vir is chasing the same market.
90
For the first time in decades, America is about to start refining raw tin at scale. A first-of-its-kind plant in Henry County, Virginia, is set to begin production in 2027. A new deal secures its supply: up to 3,600 metric tons a year from the Democratic Republic of the Congo. Tin holds together the circuit boards in your phone, your car, and our defense systems. American workers will now smelt Congolese tin in the United States, creating jobs on both sides of the Atlantic. That is Pax Silica and the U.S.-DRC Strategic Partnership Agreement at work. mining.com/alphamin-directs-…
151
456
88
1,350
159,166
Faeth Thera $FTH printed "positive" Phase 2 data this morning. Stock went from +18% to -22% premarket. Headline: 33% confirmed response (12/36). 44% in PIK3CA-mutant (7/16). Fine print: single-arm, no control. And 64% grade 3+ treatment-related side effects, under a release that says "generally well tolerated." Next up: they want a Phase 3. The market already voted on the toxicity given it finished down 42%.
164
Zura Bio $ZURA down ~68% premarket after tibulizumab missed its Phase 2 in hidradenitis suppurativa. AN count reduction at week 16: 300 mg: 56.0% 150 mg: 58.1% Placebo: 52.5% That's the story. The drug didn't fail to move patients. Placebo moved them almost as much. HS keeps punishing trials with huge placebo responses. If you can't separate signal from noise in who responds, you need a bigger trial or a smarter one.
2
425
Merlin_Asset retweeted
Important Fact About Sam Cooper: The Liberal Government & All Liberal Operatives HATE SAM For the last 15 Years the Liberal Establishment has insisted everything Sam publishes is untrue or distorted But in the end, this is what we learn about Sam' work: EVERY WORD IS TRUE
Key post from @scoopercooper (Aug 24, 2026): “I’d be worried if I was a Canadian bank or developer etc with exposure to Iranian currency exchanges and Chinese underground banking, that is major exposure risk given Bessent’s announcement. Speaking of economic warfare. People don’t know the half of the tools available to DC.” @scoopercooper This was posted the same day Treasury Secretary Scott Bessent launched Operation Economic Outcast, an aggressive campaign to sever Iran’s financial lifelines (including digital assets, secondary sanctions on facilitators, and targeting networks enabling IRGC funding). home.treasury.gov
68
800
14
2,889
47,931
This is mind blowing to me……TIA though. This is Africa. #gold
AFRICA ‘PREMIUM GOLD’ seller shows off his operation on INSTAGRAM Workers form HUMAN CONVEYOR BELT, passing material DOZENS OF METERS through mine
94
Servier’s $1.55B bet for Edgewise's sevasemten just backfired. This week the 175-patient, 18-month Becker muscular dystrophy pivotal missed its primary endpoint and every secondary. A biomarker win isn't a functional win. $EWTX The warning was in the Phase 2. It won on a biomarker (creatine kinase) but never hit significance on the same functional scale the pivotal used.
222